Immature human monocyte-derived dendritic cells migrate rapidly to draining lymph nodes after intradermal injection for melanoma immunotherapy

Melanoma Research

Volumn 9, Issue 5, 1999, Pages 474-481

  Thomas, R ^a   Chambers, M ^a   Boytar, R ^b   Barker, K ^a   Cavanagh, L L ^a   MacFadyen, S ^a   Smithers, M ^a   Jenkins, M ^b   Andersen, J ^b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

Dendritic cells; Human; Immature; Immunotherapy; Migration

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; INTERLEUKIN 4;

ADOPTIVE IMMUNOTHERAPY; ADULT; AGED; ANTIGEN PRESENTING CELL; ARTICLE; CANCER IMMUNOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DENDRITIC CELL; DOSE TIME EFFECT RELATION; FEMALE; GAMMA SCINTIGRAPHY; HUMAN; HUMAN CELL; INTRADERMAL DRUG ADMINISTRATION; LEUKOCYTE COUNT; LEUKOCYTE MIGRATION; MALE; MELANOMA; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SERUM; TREATMENT OUTCOME;

EID: 0032723761     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-199910000-00007     Document Type: Article

References (30)

1. Kimber I, Cumberbatch M. Stimulation of Langerhans cell migration by tumor necrosis factor-α (TNF-α). J Invest Dermatol 1992; 99: 48S-50S.
2. Steinman RM. The dendritic cell system and its role in immunogenicity. Ann Rev Immunol 1991; 9: 271-296.
3. Mayordomo JI, Zorina T, Storkus WJ, Zitvogel L, Celluzzi C, Falo LD, Melief CJ, Ildstad ST, Kast WM. Deleo AB, et al. Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity. Nature Med 1995; 1: 1297-1302.
4. Zitvogel L, Mayordomo JI, Tjandrawan T, Deleo AB, Clarke MR, Lotze MT, Storkus WJ. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines. J Exp Med 1996; 183: 87-97.
5. Nestle FO, Alijagic S, Gilliet M, Sun Y, Grabbe S, Dummer R, Burg G, Schadendorf D. Vaccination of melanoma patients with peptide- or tumour lysate-pulsed dendritic cells. Nature Med 1998; 4: 328-332.
6. Murphy G, Tjoa B, Ragde H, Kenny G, Boynton A. Phase I clinical trial: T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen. Prostate 1996; 29: 371-380.
7. Hsu FJ, Benike CJ, Fognoni FF, Liles TM, Czerwinski D, Taidi B, Engleman EG, Levy R. Vaccination of patients with B cell lymphoma using autologous antigen-pulsed dendritic cells. Nature Med 1996; 2: 52-58.
8. Romani N, Gruner S, Brang D, Kampgen E, Lenz A, Trockenbacher B, Konwalinka G, Fritsch PO, Steinman RM, Schuler G. Proliferating dendritic cell progenitors in human blood. J Exp Med 1994; 180: 83-93.
9. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 1994; 179: 1109-1118.
10. Bender A. Sapp M, Schuler RM, Bhardwaj N. Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. J Immunol Methods 1996; 196: 121-135.
11. Romani N, Reider D, Heuer M, Ebner O, Kampgen E, Eibl B, Niederwieser D, Schuler G. Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. J Immunol Methods 1996; 196: 137-151.
12. Peters AM, Danpure HJ, Osman S, Hawker RJ, Henderson BL, Hodgson HJ, Kelly JD, Neirinckx RD, Lavender JP. Clinical experience with 99mTc-hexamethylpropylene-amineoxime for labeling leucocytes and imaging inflammation. Lancet 1986; ii: 946-949.
13. Storkus WJ, Zech HJ, Salter RD, Lotze MT. Identification of T-cell epitopes: rapid isolation of class I-presented peptides from viable cells by mild acid elution. J Immunother 1993; 14: 94-103.
14. Kelbaek H, Linde J, Nielsen SL. Evaluation of a new leukocyte labeling procedure with 99mTc-HMPAO. Eur J Nucl Med 1988; 14: 621-623.
15. Pettit AR. Quinn C, MacDonald KPA, Cavanagh LL, Thomas G, Townsend W, Handel M, Thomas R. Nuclear localization of RelB is associated with effective antigen presenting cell function, J Immunol 1997; 159: 3681-3691.
16. Mosialos G, Birkenbach M, Ayehunie S, Matsumura F, Pinkus GS, Kieff E Langhoff E. Circulating human dendritic cells differentially express high levels of a 55-kd actin-bundling protein. Am J Pathol 1996; 148: 593-600.
17. Cavanagh LL, Saal RJ, Grimmett KL, Thomas R. Proliferation in monocyte-derived dendritic cell cultures is due to progenitor cells capable of myeloid differentiation. Blood 1998; 92: 1598-1607.
18. Thomas R, Quinn C. Functional differentiation of dendritic cells in rheumatoid arthritis: role of CD86 in the synovium. J Immunol 1996; 156: 3074-3086.
19. Sallusto F, Cella M, Danieli C, Lanzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocmpatibility complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med 1995; 182: 389-400.
20. De Smedt T, Pajak B, Muraille E, Lespagnard L, Heinen E, De Baetselier P, Urbain J, Leo O, Moser M. Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo. J Exp Med 1996; 184: 1413-1424.
21. Nathanson SD, Nelson L, Karvelis KC, Rates of flow of technetium 99m-labeled human serum albumin from peripheral injection sites to sentinel lymph nodes. Ann Surg Oncol 1996; 3: 329-335.
22. Fossum S. Lymph-borne dendritic leucocytes do not recirculate, but enter the lymph node paracortex to become interdigitating cells, Scand J Immunol 1988; 27: 97-105.
23. Smith JB, McIntosh GH, Morris B. The traffic of cells through tissues: a study of peripheral lymph in sheep. J Anat 1970; 107: 87-100.
24. Hopkins J, McConnell I, Budjoso R, Munro AJ. Studies of MHC class II products on sheep peripheral and efferent lymph cells. In: Morris B, Miyasaka M, eds. Immunology of the Sheep. Basel: Editiones Roche, 1985; 441.
25. Hall JG, Morris B. The origin of cells in the efferent lymph from a single lymph node, J Exp Med 1965; 121: 901.
26. Barratt Boyes SM, Watkins SC, Finn OJ. In vivo migration of dendritic cells differentiated in vitro: a chimpanzee model. J Immunol 1997; 158: 4543-4547.
27. Dieu MC, Vanbervliet B, Vicari A, Bridon JM, Oldham H, Ait Yahia S, Briere F, Zlotnik A, Lebecque S, Caux C. Selective recruitment of Immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J Exp Med 1998; 188: 373-386.
28. Sozzani S, Allavena P, G DA, Luini W, Bianchi G, Kataura M, Imai T, Yoshie O, Bonecchi R, Mantovani A. Differential regulation of chemokine receptors during dendritic cell maturation: a model for their trafficking properties. J Immunol 1998; 161: 1083-1086.
29. Peters AM. The utility of [99mTc]HMPAO-leukocytes for imaging infection. Semin Nucl Med 1994; 24: 110-127.
30. Morse MA, Coleman RE, Akabani G, Niehaus N, Coleman D, Lyerly HK. Migration of human dendritic cells after injection in patients with metastatic malignancies. Cancer Res 1999; 59: 56-58.